Multidetector computerized tomography can guide and document alcohol septal ablation in hypertrophic obstructive cardiomyopathy

Circulation

Volumn 123, Issue 2, 2011, Pages

  Ghersin, Eduard ^a   Soto, Victor ^a   Heldman, Alan W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; METOPROLOL; SUCCINIC ACID; VERAPAMIL;

ABLATION THERAPY; ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; FEMALE; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MEDICAL HISTORY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT PREFERENCE; PERCUTANEOUS TRANSCORONARY ALCOHOL SEPTAL ABLATION; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ETHANOL; FEMALE; HUMANS; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 78751605593     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.975599     Document Type: Article

References (4)

1. Kelley-Hedgepeth A, Maron MS. Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy. Curr Heart Fail Rep. 2009;6:135-141.
2. Afonso LC, Bernal J, Bax JJ, Abraham TP. Echocardiography in hyper-trophic cardiomyopathy: the role of conventional and emerging technologies. JACC Cardiovasc Imaging. 2008;1:787-800.
3. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol. 2007;189:1335-1343.
4. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol. 2007;189:1344-1352.